Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual Event

Jun 14, 2020 9:00 AM - Jun 18, 2020 5:00 PM

(Eastern Standard Time)

Fort Washington, PA 19034

DIA 2020 Global Annual Meeting

Virtual Clinical Trials

Session Chair(s)

Nechama  Katan, MA, MS

Nechama Katan, MA, MS

Director, Statistical Programming

Pfizer Inc, United States

The term decentralized trial is not something new. However, it is becoming more mainstream as patients are more willing to participate in a clinical trial when there is less patient burden. By removing barriers of trial participation, patients are more likely to be compliant, more likely to be retained, and more likely to complete the trial. Key lessons learned will be discussed as well as pitfalls to avoid in the future. What went well, what was more challenging than expected, where were the surprises.

Learning Objective : Discuss key lessons learned about decentralized trials; Describe pitfalls to avoid.

Speaker(s)

Alison  Holland

Building Connections and Building Blocks for eSource: eCOA and ePRO are the Building Blocks to Decentralized Trials

Alison Holland

Medable, United States

Executive General Manager, Digital and Decentralized Solutions

Nechama  Katan, MA, MS

A Case Study in Applying Risk-Based Monitoring Analytics to a Fully Virtual Trial

Nechama Katan, MA, MS

Pfizer Inc, United States

Director, Statistical Programming

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.